Neuroimmunomodulation

Gold Open Access Publication

All manuscripts submitted to the journal from September 15, 2022, and accepted for publication will carry the Open Access license CC BY-NC 4.0 or the license mandated by a funder. Upon acceptance, an Article Processing Charge (APC) will be levied.

New Editor-in-Chief: Rainer Straub

Learn more about the plans of Prof. Rainer Straub, the Editor-in-Chief of Neuroimmunomodulation, in the editorial: New Editor-in-Chief’s Note: The Past and the Future

Check Out Our Article Collections

Best of Neurodegenerative Diseases

Neuroinflammation in infectious Diseases

Neuroinflammation in Neurodegenerative and Psychiatric Diseases